Development of respiratory syncytial virus vaccines

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1429, 2004-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The development of antiviral therapy and vaccines against respiratory syncytial virus and human parainfluenza virus type 3

By A J.E.

International Journal of Pharmaceutical Medicine, Vol. 15, Iss. 4, 2001-08 ,pp. : 175-190

Adis International

Access to resources Recommend Favorite

Inflammatory Responses to Respiratory Syncytial Virus (RSV) Infection and the Development of Immunomodulatory Pharmacotherapeutics

Current Medicinal Chemistry, Vol. 19, Iss. 10, 2012-04 ,pp. : 1424-1431

Bentham Science Publishers

Access to resources Recommend Favorite

Respiratory syncytial virus antiviral agents

By Prince G.A.

Expert Opinion on Therapeutic Patents, Vol. 9, Iss. 6, 1999-06 ,pp. : 753-762

Informa Healthcare

Access to resources Recommend Favorite

Impact of Respiratory Syncytial Virus: The Nurse's Perspective

By Bracht Marianne

Drugs in R&D, Vol. 11, Iss. 3, 2011-09 ,pp. : 215-226

Adis International

Access to resources Recommend Favorite

Emerging drugs for respiratory syncytial virus infection

By Olszewska Wieslawa Openshaw Peter

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 207-217

Informa Healthcare

Access to resources Recommend Favorite